Уважаемые пользователи!
Мы рады представить вам новую версию сайта с улучшенным интерфейсом и новыми возможностями.
Приглашаем вас ознакомиться и поделиться обратной связью. Спасибо, что вы с нами!
Попробовать!

The 4th Global Educational Forum "Russian Cardiovascular Days" was successfully carried out in Saint-Petersburg

25.04.20162232
Once again this significant meeting was held jointly be the European Society of Cardiology and Russian Society of Cardiology.

USPSTF recommends low-dose aspirin for cardiovascular disease, colorectal cancer prevention

15.04.20162587
The U.S. Preventive Services Task Force has issued a final recommendation statement in support of the initiation of aspirin for the primary prevention of cardiovascular disease and colorectal cancer.

Myocardial infarction may present in patients with early SLE

14.04.20162892
Some patients with systemic lupus erythematosus experienced myocardial infarction prior to or shortly after their lupus diagnosis, according to a recently published report.

INFORM: CTEPH underdiagnosed in patients with PE

13.04.20162678
As many as 4% of patients with pulmonary embolism may develop chronic thromboembolic pulmonary hypertension, but imaging studies in patients with pulmonary embolism and a symptom of pulmonary hypertension are underutilized, according to new research published in the American Journal of Medicine.

Hand-held devices including smartphones can be adapted to detect arrhythmia

12.04.20162666
Hand-held devices such as smartphones can be adapted to allow the phone to monitor a persons heart and detect atrial fibrillation with a high degree of accuracy, researchers reported here.

FDA Warns of Heart Failure Risk With Two Diabetes Drugs

11.04.20162660
The US Food and Drug Administration (FDA) has issued a new alert about the potential for increased risk for heart failure in patients taking the type 2 diabetes drugs saxagliptin (Onglyza, AstraZeneca Pharmaceuticals LP) and alogliptin (Nesina, Takeda Pharmaceuticals).

Benefits and Harms of Oral Anticoagulation in Patients With Atrial Fibrillation and Prior Intracranial Hemorrhage

08.04.20162335
What are the risks and benefits in atrial fibrillation (AF) patients with previous intracranial hemorrhage (ICH) treated with warfarin, compared to antiplatelet or no antithrombotic therapies?
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.